PIK3CA mutation frequencies are different among breast cancer subtypes: 34.5–45%, 22.7–39% and 8.3–25% in HR+, HER2+ and in triple negative breast cancers (TNBC), respectively [12–14]. This evidence concerns the gene PIK3CA and breast carcinoma.